Prosthetic Valve and Graft Endocarditis With Mycobacterium Chimaera
NCT ID: NCT04429256
Last Updated: 2023-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
7 participants
OBSERVATIONAL
2020-04-10
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
So far optimal therapeutical concepts are not clear. At the University Hospital Basel Mycobacterium chimaera- infected protheses are replaced to decrease pathogenic burden and to support antibiotic long- term treatment. This study is to analyze the efficacy of this therapeutic approach.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Suppressive Antibiotic Therapy for Endocarditis
NCT06107309
Rate of Microbial Colonization Over Native Calcified Cardiac Valves
NCT01409525
Cardiac Contractility Modulation in Chagas Heart Disease
NCT05519046
Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery
NCT06196684
The China Mviv Registry
NCT05925335
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
data collection
retrospective analysis of perioperative data collected from patient medical charts and from a telephone enquiry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Reuthebuch, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Cardiac Surgery Clinic University Hospital Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiac Surgery Clinic University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Req-2020-00373;ch20Reuthebuch2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.